Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FFQMK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,527
Award facts
- Contract value 100% obligated
- $12,526.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,526.64 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors (2 mL quantity) with a firm fixed price. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order at its corporate office location in Conshohocken, PA. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis with nasal polyps, making it a critical pharmaceutical product for military and federal healthcare systems.
This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for pharmaceutical procurement to support military healthcare programs globally. The company's extensive contract portfolio with DLA demonstrates its established capability to supply a comprehensive range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The competitive award reflects AmerisourceBergen Drug Corp's position as a critical vendor within the Defense Health Agency's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FFQMK?
SPE2DB25FFQMK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FFQMK worth?
The government has obligated $12,527 on SPE2DB25FFQMK.
Is contract SPE2DB25FFQMK an order under another contract?
Yes. SPE2DB25FFQMK is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFQMK competed?
The extent of competition for SPE2DB25FFQMK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award